Jian Liu

Jian Liu has an extensive work experience spanning several companies and roles. Jian is currently serving as the President of the Drug Discovery Division at Shanghai Medicilon Inc. since June 2023. Previously, from July 2022 to May 2023, they held the position of Chief Executive Officer at Silexon AI. Before that, Jian Liu worked at Eternity Bioscience, Inc as the Chief Scientific Officer and Site Head from August 2020 to April 2022.

Jian also gained valuable experience at Merck, where they held various roles such as Principal Scientist from August 2012 to August 2020, Research Fellow and Chemistry team lead from April 2005 to July 2012, and Sr. Research Chemist from February 2001 to April 2005. Jian'searliest work experience was as a Lecturer at Tsinghua University, where they worked from April 1991 to September 1994.

Jian Liu pursued their education in the field of Chemistry. Jian obtained a Bachelor's degree from Peking University, although the specific dates of this achievement are unknown. Later, they pursued a Master's degree at Tsinghua University, but the start and end years for this program are not provided.

Continuing their academic journey, Jian Liu obtained a Ph.D. in Chemistry from UCLA, where they studied under the guidance of Ken Houk. This program took place from 1994 to 1998.

Post-Ph.D., Jian Liu went on to further enhance their knowledge and skills through two postdoctoral positions. The first postdoc was completed at UC Irvine under the supervision of James Nowick from 1998 to 1999. Following this, they embarked on another postdoc at the University of Pennsylvania, studying under the guidance of Amos B Smith III and Ralph Hirschmann, from 1999 to 2001.

However, the information provided does not specify any further education or academic achievements beyond these experiences.